|
PRINT COMPANY INFORMATION
| Market Information: |
| Last Trade: |
Not Traded Today |
| Last Update |
May 26, 2013 at 10:02AM |
| Change |
|
Not Traded Today |
|
Not Traded Today |
|
| |
|
| Open Price |
0.0 |
| Adjusted Open Price |
74.4 |
| Yesterday Close Price |
74.4 |
|
| |
| Close Price |
0.0 |
| |
|
| Day's Range |
0.0 - 0.0 |
| |
|
| Volume |
0 |
| |
|
| Total Trade |
0 |
| |
|
| Market Cap in BDT* |
1205.28 (mn) |
|
| |
|
|
|
| Basic Information: |
|
|
|
| Authorized Capital in BDT* (mn) |
500.0 |
|
|
| Paid-up
Capital in BDT* (mn) |
162.0 |
52 Week's Range |
70 - 107.4 |
| |
|
|
|
| Face Value |
10.0 |
Market Lot |
100 |
| |
|
|
|
| Total no. of Securities |
16200000 |
Business Segment |
Pharmaceuticals & Chemicals |
|
VIEW CLOSE PRICE GRAPH FOR
LAST ONE MONTH
LAST ONE YEAR
VIEW TOTAL TRADES GRAPH FOR
LAST ONE MONTH
LAST ONE YEAR
| Last AGM Held: 23/06/2012 |
| Bonus Issue |
25% 2011, 20% 2010, 20% 2009 |
| |
|
| Right Issue |
n/a |
| |
|
| Year End |
201112 |
| |
|
| Reserve & Surplus in BDT* (mn) |
166.74 |
|
| Interim
Financial Performance: 2013 |
Particulars |
Unaudited
/ Audited |
| Q1(3 Months)
|
Q2(6 Months)
|
Q3(9 Months)
|
Q4 (12 Months)
|
|
201303 |
|
|
|
Turn Over in BDT* (mn)
|
451.01 |
n/a |
n/a |
n/a |
Net Profit After Tax in BDT *(mn) (Continuing Operations)
|
12.8 |
n/a |
n/a |
n/a |
| Net
Profit After Tax in BDT *(mn)
(Including Extra-ordinary Income) |
0 |
n/a |
n/a |
n/a |
Basic EPS in BDT*
(Based on continuing operations) |
0.790 |
n/a |
n/a |
n/a |
Diluted EPS in BDT* (Based on continuing
operations) |
|
0.660 |
n/a |
n/a |
n/a |
Basic
EPS in BDT*
(Including Extra-ordinary Income) |
0.000 |
n/a |
n/a |
n/a |
Diluted EPS in BDT* (Including Extra-ordinary Income) |
|
0.000 |
n/a |
n/a |
n/a |
|
Profit Status :
| |
Basic |
Diluted |
Current Price Earning Ratio (P/E)
(Based on Continuing operation)
|
23.54 |
28.18 |
Current Price Earning Ratio (P/E)
(Including Extra-ordinary Income) |
|
|
* Note - Based on Annualized
EPS of 2013 (Q1)
Price Earning Ratio Based
on last Audited Financials:
Current Price Earning Ratio (P/E)
(Based on Continuing Operation)
|
17.03 |
Current Price Earning Ratio (P/E)
(Including Extra-ordinary Income) |
|
* Note - Based on
audited EPS of 2011
| Year |
Basic
EPS |
Basic
EPS (restated) |
Net Asset Value Per Share |
Restated
Net Asset Value Per Share |
Net Profit After Tax (mn) |
| Based on |
Based on |
| Continuing operations |
Including
Extra-Ordinary Income |
Continuing operations |
Including Extra-Ordinary
Income |
Continuing operations |
Including Extra-Ordinary
Income |
| 2000 |
21.61 |
n/a |
n/a |
n/a |
117.51 |
n/a |
19.45 |
n/a |
| 2001 |
24.56 |
n/a |
n/a |
n/a |
124.08 |
n/a |
22.11 |
n/a |
| 2002 |
31.56 |
n/a |
n/a |
n/a |
141.22 |
n/a |
28.42 |
n/a |
| 2003 |
32.28 |
n/a |
n/a |
n/a |
151.50 |
n/a |
29.05 |
n/a |
| 2004 |
31.85 |
n/a |
n/a |
n/a |
160.24 |
n/a |
28.66 |
n/a |
| 2005 |
36.40 |
n/a |
n/a |
n/a |
198.75 |
n/a |
32.76 |
n/a |
| 2006 |
22.82 |
n/a |
n/a |
n/a |
179.57 |
n/a |
20.54 |
n/a |
| 2007 |
31.19 |
n/a |
n/a |
n/a |
187.75 |
n/a |
28.07 |
n/a |
| 2008 |
48.09 |
n/a |
n/a |
n/a |
209.64 |
n/a |
43.29 |
n/a |
| 2009 |
54.70 |
n/a |
45.59 |
n/a |
239.34 |
199.45 |
49.23 |
n/a |
| 2010 |
5.562 |
n/a |
4.635 |
n/a |
24.883 |
20.735 |
60.07 |
n/a |
| 2011 |
5.46 |
n/a |
4.37 |
n/a |
25.37 |
20.29 |
70.81 |
n/a |
| 2012 |
n/a |
n/a |
n/a |
n/a |
n/a |
n/a |
n/a |
n/a |
|
|
All figures in BDT (Bangladeshi Taka) |
| Financial Performance (Continue): |
| Year |
Year End P/E |
% Dividend |
% Dividend Yield |
| Based on |
| Continuing operations |
Including
Extra-Ordinary Income |
| 2000 |
11.66 |
n/a |
16.00 |
6.35 |
| 2001 |
12.66 |
n/a |
18.00 |
5.79 |
| 2002 |
12.69 |
n/a |
20.00 |
4.99 |
| 2003 |
24.09 |
n/a |
20.00 |
2.57 |
| 2004 |
25.14 |
n/a |
21.00 |
2.62 |
| 2005 |
13.85 |
n/a |
21.00 |
4.17 |
| 2006 |
21.78 |
n/a |
21.00 |
4.23 |
| 2007 |
25.23 |
n/a |
23.00 |
2.92 |
| 2008 |
20.70 |
n/a |
25.00 |
2.52 |
| 2009 |
34.05 |
n/a |
7.50, 20%B |
0.48 |
| 2010 |
34.86 |
n/a |
10.00, 20%B |
0.62 |
| 2011 |
30.96 |
n/a |
10.00, 25%B |
0.74 |
| 2012 |
n/a |
n/a |
n/a |
n/a |
|
| Details of Financial Statement |
|
| Price Sensitive Information |
|
| Other Information of the Company: |
| Listing Year |
1989 |
| |
|
| Market Category |
A |
| |
|
| Electronic Share |
Y |
| |
|
| Share Percentage: |
| Sponsor/Director 48.07 |
Govt.0 |
Institute 12.99 |
Foreign 0 |
Public 38.94 |
|
| Remark |
1. The Face Value of the securities has been changed into TK 10. The No. of Shares, Market Lot, EPS, NAV and DPS have been changed accordingly. |
|
| Address of the Company: |
| Address: |
House # 41, Road # 10/A, Dhanmondi R/A, Dhaka - 1200. |
| |
|
| Contact Phone: |
9114710, 9117496, 9132521 |
| |
|
| Fax: |
880 - 02 - 8118432, 8110315 |
| |
|
| E-mail: |
ibnsina@bangla.net |
| Web Address: |
http://www.ibnsinapharma.com
|
|
* BDT - Bangladeshi Taka
STOCK EXCHANGE BUILDING, 9/F MOTIJHEEL C/A, DHAKA BANGLADESH
Phone: 88-02-9564601, 7175703-11, FAX: +88-02-9564727
Email: dse@bol-online.com, Web: http://www.dsebd.org/
|
 |
